P olypharmacy, the receipt of multiple medications and variably defined according to different cutpoints, 1,2 is common in older persons. Of Medicare Part D enrollees in 2012, 48% filled four or more prescriptions per month, and 19% filled eight or more. 3 Although the data are mixed, the majority of studies examining polypharmacy have demonstrated associations with a range of undesirable outcomes, including adverse drug events, falls, hospitalization, physical and cognitive disability, and hospitalization. 4 The greater the number of total prescribed medications, the greater was the likelihood of prescription of a medication individually associated with risk of harm, otherwise known as a potentially inappropriate medication (PIM).
A recent review of deprescribing trials to reduce polypharmacy and PIMs concluded that the most-effective trials involved resource-intensive interventions such as multidisciplinary team medication review and academic detailing. 6 These interventions have the advantage of identifying a wide range of PIMs based on implicit review and clinical expertise. A second review of studies using lessresource-intensive e-prescribing and computerized decision support system (CDSS) technologies found that many were successful in reducing the use of certain medications or classes of medications. 7 Although these interventions have the potential for more-widespread dissemination, they generally target a narrow range of PIMs.
The Tool to Reduce Inappropriate Medication (TRIM) was designed to bridge the gap between these two types of interventions. 8 TRIM links a CDSS to the Department of Veterans Affairs electronic health record (EHR) and evaluates the appropriateness of the medication regimen, providing feedback to patients and clinicians. It supplements EHR data with components of patient assessment necessary to perform a comprehensive medication reconciliation and to facilitate an assessment of appropriateness in the context of individual patient characteristics not reliably found in the medical record. Decisions about medication appropriateness in older adults involve consideration of benefits and harms and how these relate to patient goals 9 in a process of shared decision-making. 10 By alerting clinicians to PIMs and potentially inappropriate regimens, the feedback that TRIM generates is designed to prompt clinicians to ask patients about adverse effects specifically and their experience with medications more generally. TRIM also provides simplified feedback to patients, focusing on patient-reported discrepancies and problems, to enhance patient self-efficacy in discussing these issues with their clinicians. The purpose of the current study was to examine the effects of TRIM on shared decision-making about medications. The primary outcomes were patients' perceptions about participation in their care and patient-clinician medication-related communication. The secondary outcomes were changes in the medication regimen.
METHODS

Participants
The sample size of 128 was calculated to provide power of 0.80 for a two-sided test with a Type 1 error of 0.05 to detect an effect size (Cohen d) of 0.5 for continuous outcomes. Participants were community-dwelling veterans aged 65 and older with an upcoming primary care appointment at the Veterans Affairs (VA) Connecticut Healthcare System who were prescribed seven or more medications including at least one each for hypertension and diabetes mellitus (DM). From December 2014 through January 2016, consecutively eligible veterans were mailed an opt-out letter followed by a telephone call to screen for exclusion criteria (severe hearing loss, prescription of medications by clinician(s) outside of the VA, medication management by someone other than the veteran, severe acute illness). Eligible participants were assigned to receive the TRIM intervention or usual care, with half of those in the usual care group receiving the TRIM telephone assessment, as described further below. To avoid clinicians seeing control and intervention patients simultaneously, assignments were made in blocks of time, such that, for each period of time, all eligible patients were assigned to a given group. Written informed consent was obtained from all participants, and the Human Subjects Subcommittee of the VA Connecticut Healthcare System approved the protocol. The trial was registered at Clinical Trials.gov (NCT02501967). A flow diagram is provided in Figure 1 .
Intervention
The development of TRIM has been previously described. 8 It consists of two web applications. The first extracts information on medications and chronic conditions from the EHR. The second consists of three components. The first is an interface for data chart review and telephonic patient assessment. These data, along with the extracted EHR data, serve as inputs for the second component, a set of automated algorithms evaluating medication appropriateness. TRIM evaluates medication appropriateness based on a range of criteria, including feasibility in the context of the patient's cognition and social support, potential overtreatment of DM or hypertension, "traditional" PIMs according to Beers and Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP) criteria, inappropriate renal dosing, and patient report of adverse medication effects. The algorithms generate the third component, a patient-specific medication management feedback report for the clinician. This report includes a complete medication reconciliation, recommendations for discontinuation or dosage changes for inappropriate medications, and a recommendation regarding the need to simplify the regimen of patients with problems with adherence and poor social support. The report was e-mailed to the clinician 24 hours before the primary care appointment and handed to the clinician just before the appointment. The algorithms also generate a simple, short report for the patient consisting of a listing of medication reconciliation discrepancies and reported problems with medications that is given to the patient just before the appointment with brief coaching on using it to discuss medication concerns with the clinician. The telephone assessments occurred within 3 days before their primary care appointment.
Control Group
The control group received usual care. Performance of the TRIM telephone assessment was necessary to identify potential medication problems to compare changes in the medication regimen according to intervention assignment. There was concern that this assessment, even without provision of feedback reports, could influence medication decision-making. We balanced the need for assessment with concern about its effects on prescribing by performing the TRIM telephone assessment on only half of the control group. These participants (control + assessment) received the assessment within 3 days before the primary care appointment; neither they nor their physicians received a feedback report.
Data Collection and Measures
The primary care visits were audio recorded to analyze the communication between the patient and clinician; for nine visits, the patient or clinician refused to be recorded, or the audio file was of insufficient quality to be analyzed. Patients were interviewed directly after their visits, and a chart review was performed 90 days after the visit by a researcher who was not blinded to study assignment. The primary outcome measures were patient involvement in their care and patient-clinician communication. Patient involvement was measured using a sum of the scores of three subscales from the Patient Assessment of Care for Chronic Conditions (PACIC). 11 The PACIC was developed as a patient self-report measure on receipt of patient-centered care. As the scale's developers recommended, 11 we selected the subscales most relevant to shared decisionmaking: patient activation, goal setting, and problem-solving and contextual counseling. The original PACIC asks patients to report on the frequency with which they engaged in certain behaviors in their chronic illness care over the previous 6 months. Because we used the PACIC to evaluate a single clinic visit, we modified the response choices to ask the patient whether they engaged in the behavior during the visit, resulting in a range of scores from 0 to 12.
The clinician-patient communication variables consisted of active patient participation, clinician facilitation of patient participation, and communication about medication. Active patient participation was coded using the Active Patient Participation Coding Scheme, which identifies the presence of three types of patient speech-questions, assertive responses (e.g., stating preferences, making requests, introducing topics to discuss), and expressions of concern 12 -each of which influences a clinician's behavior and treatment. 12, 13 The scheme also identifies two types of clinician communication aimed at facilitating active participation: partnership-building responses (e.g., soliciting patient opinions, concerns, or questions) and supportive talk (e.g., reassurance, encouragement).
14 Clinician and patient communication related to medication management was coded using a scheme adapted from earlier studies. 15, 16 The medication-related communication was coded by identifying utterances pertaining to medication adverse effects, medication instructions and assistance with Secondary outcomes were changes in patients' medication regimens. The change in total number of medications from baseline to 90 days was calculated. For patients in the intervention and control + assessment groups, the medication list was examined to evaluate the number of TRIM recommendations that were implemented and the number of medication discrepancies corrected.
Data regarding characteristics used to describe the study population were obtained from interview and chart review. Patients provided self-report of education, ethnicity, sufficiency of monthly income, employment status, quality of life, and self-rated health. Information on age and chronic conditions was obtained from chart review.
Analysis
Characteristics of the participants in the intervention and control groups were examined using univariate statistics. The PACIC was dichotomized as a score of 11 or 12 versus 10 or less to evaluate the proportion of individuals who reported participation in all or nearly all of the activities related to patient-centered care. As a sensitivity analysis, we examined the PACIC with a cut-point of 10. The communication variables were examined as continuous outcomes, except for clinician recommendation, which was dichotomized as 1 or more recommendations versus none. The significance of bivariate associations was analyzed using chi-square tests for categorical outcomes and nonparametric Kruskal-Wallis tests for continuous outcomes, although means are also presented for ease of interpretation. Multivariable analyses were conducted using generalized estimating equations and mixed models to account for clustering of patients receiving care from the same clinician. These analyses also adjusted for imbalances in the intervention and control groups and for variables associated with each of the outcomes at P < .10. Further analyses of the communication variables examined the relationship between patient and clinician communication, because the two can influence each other. 17, 18 Clinician facilitative communication was added to the model examining the outcome of patient active communication, and patient active communication was added to the model examining the outcome of clinician facilitative communication. In the same way, clinician and patient medication communication variables were added to the reciprocal models.
RESULTS
A total of 128 patients were assigned to the intervention and control groups (Table 1) . Few women participated in the study, and most participants were white. Fewer patients in the intervention group were married, had a college education, or money left over at the end of the month, and more were employed and rated their health as excellent or very good.
TRIM found potential problems with virtually all medication regimens ( Table 2 ). The feedback report for 98% of intervention and 97% of control participants Because only one-half of the control group had medication appropriateness examined by TRIM, N = 32 for "Recommendations."
noted discrepancies in the medications they reported taking at home and the medications in their record. The clinician feedback report included at least one recommendation for 93% of intervention and 100% of control participants to discontinue or decrease a PIM or to simplify the medication regimen. Approximately half of participants had one or more PIMs as identified using Beers and STOPP criteria, more than three-quarters had potential overtreatment of hypertension, and more than 30% had potential overtreatment of DM. More than 30% also reported low adherence /or had cognitive impairment as indicators of the need to simplify the regimen.
In bivariate analysis, a greater proportion of patients who received TRIM than control patients reported a PACIC score of 11 or 12, but this difference was not significant (29.7% vs 15.6%, P = .06) ( Table 2) . In sensitivity analysis, using a cut-point for the PACIC of 10, 54.6% of intervention patients and 34.4% of control patients reported a high PACIC score (P = .02). In adjusted analysis, controlling for clustering and potential confounders, participants who received TRIM were 2.8 times as likely to report a score of 11 or 12 as control participants (P = .10).
Patients who received TRIM had significantly more active participation and medication-related communication than controls. The clinicians of patients who received TRIM demonstrated significantly more facilitative and medication-related communication than clinicians of control patients, and a significantly larger proportion made a medication-related recommendation (Table 3) . These differences were maintained after adjustment for clustering and potential confounding (Table 4 ). There were no differences between intervention and control patients in number of medications prescribed at 90 days or in the number of TRIM-related recommendations implemented, although more than three times as many medication reconciliation errors were corrected for patients who received TRIM (48.4%) than for those who did not (14.3%) (P < .001) ( Table 3) . Because only half of the control group had medication appropriateness examined using the Tool to Reduce Inappropriate Medications (TRIM), N = 32 for outcomes of proportion of medication reconciliation errors corrected and one or more TRIM recommendations implemented. Obtained from GEE models.
c
Obtained from mixed models.
When facilitative clinician communication was included in the model, the relationship between receipt of TRIM and active patient communication remained significant (P = .03). In contrast, when active patient communication was included in the model, the relationship between receipt of TRIM and clinician facilitative communication was no longer significant (P = .39). This same pattern held true for patient and clinician medication-related communication (Table 3) .
DISCUSSION
In this randomized controlled trial conducted in older veterans prescribed seven or more medications, including for DM and hypertension, the use of TRIM significantly improved medication-related communication and was associated with a nonsignificant increase in the proportion of veterans providing the highest ratings of patient-centered care most relevant to medication management. Its use also significantly improved the accuracy of the medication list. There was no association between use of TRIM and medication prescribing, although the small sample size did not provide adequate power to examine this outcome.
Appropriate prescribing in older adults requires a process of shared decision-making. The results of this study suggest that TRIM was successful in promoting this process. Because there is no medication-specific tool for shared decision-making, we adapted the PACIC, a general measure of patient involvement in the care of chronic conditions, using the subscales most relevant to medications. These subscales nonetheless referred to behaviors and qualities of all aspects of the care the patient received. Therefore, although the difference was not significant, the finding that a larger proportion of participants who received TRIM reported that these behaviors had occurred suggests that TRIM had an effect on the process of care.
The use of TRIM was more definitively associated with improvements in patient and clinician communication. When controlling for clinician facilitative communication, TRIM remained associated with more active patient participation, but TRIM was no longer associated with clinician communication after controlling for patient active communication. This finding suggests that TRIM had a direct effect on patients but an indirect effect on clinicians, with the patients' active communication style promoting a more participatory communication style among their clinicians. This was an unexpected finding, given that the clinicians received more extensive and detailed feedback than did patients. Other studies have shown that patients frequently have medication-related symptoms 19 and other concerns about medications 20 that they do not discuss with their physicians and desire more information about medications, 21 suggesting that only modest prompting is necessary to encourage patient communication.
The lack of a direct effect on clinician communication may help to explain the finding that the use of TRIM was not associated with changes in patients' medication regimens. Although clinicians in the intervention group responded to patients' questions and concerns about their medications, they were no more likely than those in the control group to implement the specific recommendations provided in the TRIM feedback. One study of blood pressure management in veterans with DM demonstrated that facilities with higher rates of achieving a blood pressure of 140/ 90 mmHg or less also had higher rates of potential overtreatment of hypertension. 22 This finding highlights the emphasis placed on performance improvement over the past decade without concomitant recognition of the potential for harm associated with overtreatment. These performance improvement efforts were necessary to overcome the phenomenon of clinical inertia. 23 It is likely that clinical inertia is also relevant to de-intensifying therapy and deprescribing. In one trial to reduce inappropriate prescribing, a CDSS provided primary care physicians with alerts about potential problems with prescribing. Although the CDSS reduced the number of new potentially inappropriate prescriptions, it did not have an effect on the discontinuation of preexisting inappropriate medications. 24 Patients with multiple chronic conditions can have many concerns that the clinician needs to address in a brief clinical encounter, and deprescribing may not be a priority. Although TRIM was designed to provide feedback about medications without the use of expensive clinical resources, it may not be possible to overcome inertia and other barriers to better medication prescribing without more intensive interventions such as academic detailing 6, 25 or interdisciplinary teams with the inclusion of pharmacist care.
The study lacked sufficient power for the outcome of deprescribing; 224 participants would have been required to demonstrate a difference in two medications between the intervention and control groups. Only half of control patients could be used in the analysis examining the number of TRIM recommendations that were implemented. Therefore, for the medication outcomes, this needs to be considered a pilot study, and a larger study will be necessary for more-definitive results regarding the effect of TRIM on prescribing.
In conclusion, the use of TRIM, an EHR-linked CDSS with supplementary patient assessment that delivers feedback regarding PIMs and medical regimens to primary care patients and their clinicians, improved shared decisionmaking and reduced medication reconciliation errors but did not change prescribing. The challenges of deprescribing may require more-intensive interactions with clinicians.
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